Therapeutic Asset Ratings
271 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Follicular Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
High Grade B-Cell Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Mantle Cell Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Diffuse Large B-Cell Lymphoma
Roswell Park Cancer Institute
P1
CC
(43)
Ifa
Plasma Cell Myeloma
Roswell Park Cancer Institute
P1
CC
(43)
Selvigaltin
Plasma Cell Myeloma
Roswell Park Cancer Institute
P1
CC
(43)
Survaxm
Plasma Cell Myeloma
Roswell Park Cancer Institute
P1
CC
(43)
SX682
Plasma Cell Myeloma
Roswell Park Cancer Institute
P1
CC
(43)
Talzenna
Gastroesophageal Junction Adenocarcinoma
Roswell Park Cancer Institute
P1
CC
(43)
Talzenna
Colorectal Carcinoma
Roswell Park Cancer Institute
P1
CC
(43)
TIPIRACIL
Gastroesophageal Junction Adenocarcinoma
Roswell Park Cancer Institute
P1
CC
(43)
Trifluridine
Gastroesophageal Junction Adenocarcinoma
Roswell Park Cancer Institute
P1
CC
(43)
Montanide Isa 51
Chronic Obstructive Pulmonary Disease
Roswell Park Cancer Institute
Early P1
CC
(43)
Montanide Isa 51
Pneumonia
Roswell Park Cancer Institute
Early P1
CC
(43)
Recombinant Human EGF-rP64K
Chronic Obstructive Pulmonary Disease
Roswell Park Cancer Institute
Early P1
CC
(43)
Recombinant Human EGF-rP64K
Pneumonia
Roswell Park Cancer Institute
Early P1
CC
(43)
Rapamycin
Minimal Residual Disease
Roswell Park Cancer Institute
P1/2
CC
(43)
Anti-Gpc3-Car Autologous T Lymphocytes
Hepatocellular Carcinoma
Roswell Park Cancer Institute
P1
CC
(41)
ddx5 degrader fl118
Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute
P1
CC
(41)
ddx5 degrader fl118
Malignant Pancreatic Neoplasm
Roswell Park Cancer Institute
P1
CC
(41)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
B-Cell Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
P1
CC
(41)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Richter Transformation
Roswell Park Cancer Institute
P1
CC
(41)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes
Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Roswell Park Cancer Institute
P1
CC
(41)
gb-5267 - iv only
Ovarian Cancer
Roswell Park Cancer Institute
P1
CC
(41)
Genetically Engineered Ny-Eso-1-Specific T Lymphocytes
Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P1
CC
(41)
Showing 226 to 250 of 271 assets
Previous
Page 10 of 11
Next
